Pharmaco epidemiology of drugs used in post-cataract surgery patients in tertiary care hospital


  • Geetanjali Hiremath Department of Pharmacology, Belagavi Institute of Medical Sciences, Belagavi, Karnataka, India
  • Pankajkumar Masare Department of Pharmacology, Belagavi Institute of Medical Sciences, Belagavi, Karnataka, India
  • Basavaraj C. Kotinatot Department of Pharmacology, Belagavi Institute of Medical Sciences, Belagavi, Karnataka, India



Cataract, Drug utilization study, Eye drop, Pharmacoepidemiology


Background: In India cataract is the principal cause of blindness responsible for 62.6% as per national programme for control of blindness survey and as per our knowledge, very few systematically analysed data are available on the drug utilization study pattern of medical intervention for post cataract surgery in India. Hence, the present study was under taken to generate baseline drug use data and analyse various aspects of drug prescribing practices.

Methods: This study was conducted in department of ophthalmology BIMS Belagavi. A total of 449 patients’ prescription was analysed prospectively. The data was analysed statistically, and results were expressed as numbers and percentage.

Results: A total of 2306 drugs were prescribed for 449 patients who underwent cataract surgery. All patients received topical eye drops includes bromfenac 0.1% eye drop and other one is a fixed drug combination of dexamathasone 0.1% plus ofloxacin 0.3% eye drop. Use of antibiotic in association with sex found to be significant (p- value <0.004). Average number of drugs per prescription was 5.1 and drugs which prescribed in generic name were 60.99% and overall percentage of drugs prescribed by brand name was 38.94% which includes 100% eye drops were prescribed by brand names. Fixed drug combination includes 19.50% and drugs from essential drug list used were 80.49%.

Conclusions: Health care providers have to take initiative for rational prescribing keeping in mind that it is not only a matter of national policy but also to wellbeing of individual patient.


Maiti Rituparna. Pharmacoepidemiology. Postgraduate topics in pharmacology. Paras Medical Books, Hyderabad, 2nd Ed.; 2015:206-217.

World Health Organization. Available at: Accessed 7 September 2017.

Park K. Epidemiology of chronic non-communicable Diseases and conditions. Parks text book of preventive and social medicine, Bhanarasi Bhanot publishers, Jabalapur, 24th Ed.; 2017:419-420.

Bergman U, Andersen M, Vaccheri A, Bjerrum L, Wettermark B, Montanaro N. Deviations from evidence-based prescribing of nonsteroidal anti-inflammatory drugs in three European regions. Eur J Clin Pharmacol. 2000;56:269-72.

Khurana AK, Bhawana Khurana. Diseases of lens. Comphrensive Ophthalmology. Jaypee Brothers Publishers, New Delhi, 6th Ed.; 2015:210-212.

Camesasca FI, Bianchi C, Beltrame G, Caporossi A, Piovella M, Rapisarda A, et al. Italian Betamethasone- Chloramphenicol vs Dexamethasone-Tobramycin Combination Study Group. Control of inflammation and prophylaxis of endophthalmitis after cataract surgery: a multicenter study. Eur J Ophthalmol 2007;17:733-42.

Raizman MB, Donnenfeld ED, Weinstein AJ. Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery. Curr Med Res Opinion. 2007 Oct 1;23(10):2325-31.

Stifter E, Menapace R. Instant vision compared with postoperative patching: clinical evaluation and patient satisfaction after bilateral cataract surgery. Am J Ophthalmol 2007;143:441-8.

Heuermann T, Anders N, Rieck P, Hartmann C. Peribulbar aesthesia and prophylaxis of postoperative endophthalmitis after cataract surgery. J Cataract Refract Surg. 2000;35:1523-31.

Pianini V, Passani A, Rossi GC, Passani F. Efficacy and safety of netilmcin/dexamethasone preservative free and to bramycin/dexamethasone-preserved fixed combination in patients after cataract surgery. J Ocular Pharmacol. 2010;26:617-21.

Biswas S, Mondal KK, Halder S, Sarkar SS, Maiti T, Lahiri SK, et al Pharmaco-epidcemiology of drugs utilised for cataract surgery in a government medical college and hospital. J Indian Med Assoc. 2010 Dec;108(12):829-32.

Agrawal NK, Gupta N. Pharmaco-epidemiology of drugs used in post cataract surgery patients in tertiary care hospital in north India - a prospective observational study. World J Pharmaceut Res. 2015:4(06):1618-28.

Shankar PR, Upadhyay DK, Subish P, Bhandari RB, Das B. Drug utilisation among older inpatients in a teaching hospital in Western Nepal. Singapore Med J. 2010 Jan 1;51(1):28.

Gross F, Drug utilization therapy and practice. The present situation in Federal Republic of Germany. Eurp J Clin Pharmacol. 1981;19:387‐94.

Maini R, Verma KK, Biswas NR, Agrawal SS. Drug utilization study in dermatology in a tertiary hospital in Delhi. Indian J Physiol Pharmacol. 2002 Jan 25;46(1):107-10.

George KK, Narmadha S, Nagarajan M. A study on drug prescribing pattern in Madurai city. Indian J Pharmacol. 2002 Sep 1;34(5):361.

Sharma SC, Uppal R, Sharma PL, Kaur S. Rational use of topical corticosteroids in dermatology. Indian J Pharmacol. 1990 Jul 1;22(3):141.

Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A. A survey on polypharmacy and use of inappropriate medications. Toxicol Int. 2012;19(1):68-73.

Nolan L, O'Malley K. Prescribing for the elderly part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatrics Soc. 1988 Feb;36(2):142-9.

Jensen MK, Fiscella RG, Moshirfar M, MooneyB. Third and fourth generation fluoroquinolones: Retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg. 2008;34:1460-7.

Endophthalmitis Vitrectomy Study (EVS) Groups. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of post- operative bacterial endophthalmitis: results of endophthalmitis vitrectomy study. Arch Ophthalmol. 1995;113:14798-896.

Vision 2020 India: The Right to sight publication - guideline for management of cataract in India. Post-operative Medications. 2011:24-25.

Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood–aqueous barrier damage and visual acuity. J Cataract Refractive Surg. 1999 Nov 1;25(11):1492-7.

Yadav AK, Patel V. Drug use in primary open angle glaucoma: A prospective study at a tertiary care teaching hospital. Indian J Pharmacol. 2013 Mar;45(2):117-20.

Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin. 2002 Jan 1;42(1):1-1.

Kshirsagar M, Langade D, Patil S, Patki PS. Prescribing patterns among medical practitioners in Pune, India. Bull World Health Organization. 1998;76(3):271.

Narwane SP, Patel TC, Shetty YC, Chikhalkar SB. Drug utilization and cost analysis of eye diseases in ophthalmology OPD of an Indian tertiary care hospital - a prescription survey. Br J Pharmaceut Res. 2011;1(1):9-18.

Biswas NR, Jindal S, Siddiquei MM, Maini R. Patterns of prescription and drug use in ophthalmology in a tertiary hospital in Delhi. Br J Clin Pharmacol. 2001 Mar;51(3):267-9.

Flach AJ. The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies. Transactions of the Am Ophthalmological Society. 2008 Dec;106:138.

Gautam CS, Sangeetha B, Goel NK, Suresh KG, Sood S. Instillation of drugs in the eye: Importance of proper instructions to patients. Indian J Pharmacol. 2001 Sep 1;33(5):386.

Goyal S, Samant BD, Parkar S.R. Pharmacoeconomic study of psychotropic drug use in psychiatry outpatient department in tertiary care teaching hospital in western India. Indian J Pharmacol. 2008;40:28.




How to Cite

Hiremath, G., Masare, P., & Kotinatot, B. C. (2018). Pharmaco epidemiology of drugs used in post-cataract surgery patients in tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 7(10), 2031–2035.



Original Research Articles